The Gastric Cancer Diagnostic Procedure Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market for gastric cancer diagnostic procedures has seen robust growth recently and is projected to expand from $1.44 billion in 2024 to $1.54 billion in 2025, registering a CAGR of 7.3%.
The Gastric Cancer Diagnostic Procedure Global Market Report 2024 forecasts that by 2029, the market will grow to $2.07 billion, with a compound annual growth rate (CAGR) of 7.6%.
Download Your Free Sample of the 2025 Gastric Cancer Diagnostic Procedure Market Report and Uncover Key Trends Now!The key drivers in the gastric cancer diagnostic procedure market are:
• Rise in point-of-care testing
• Introduction of novel biomarkers and shift towards personalized medicine
• Adoption of next-generation sequencing and enhanced endoscopic imaging modalities
• Integration of nanotechnology and big data analytics in the market
The gastric cancer diagnostic procedure market covered in this report is segmented –
1) By Procedure Type: Endoscopic Procedure, Biopsy, Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types
2) By Symptom Type: Symptomatic, Asymptomatic
3) By Offering Type: Instruments, Reagents And Consumables, Services
4) By Body Fluid Type: Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid
5) By Disease Indication: Early Gastric Cancer, Advanced Gastric Cancer
The key trends in the gastric cancer diagnostic procedure market are:
• Adoption of next-generation sequencing and enhanced endoscopic imaging modalities are influencing the market.
• Integration of nanotechnology and big data analytics are upcoming trends.
• The application of microbiota analysis is a significant emerging trend.
• An increased patient-centric approach and the role of telehealth in diagnostics are shaping the future of the market.
The major players in the gastric cancer diagnostic procedure market are:
• Pfizer Inc
North America was the largest region in the gastric cancer diagnostics procedure market in 2024